Drug Trial Radar · NCT00454662
Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)
Last checked: Nov 20, 2026Latest source record: Jan 23, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
5,141
Actual
Start
Apr 2007
Primary completion
Sep 2011
Study completion Sep 2011
Sponsor
- Lead sponsor
- COLM Study Research OrganizationAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Japan Heart Foundation
- First posted
- Apr 2, 2007
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 65 years, up to 84 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to investigate which combination therapy is more effective in reducing the incidence of cardiovascular events in Japanese elderly high-risk hypertensive patients: AT1 subtype angiotensin II receptor antagonist/calcium channel blocker or AT1 subtype angiotensin II receptor antagonist/low dose diuretic.
Conditions
- Hypertension
- Cardiovascular Disease
- Diabetes
Interventions
olmesartan medoxomil / amlodipine or azelnidipineDrug
AT1 subtype angiotensin II receptor antagonist / calcium channel blocker : 5-40mg of olmesartan medoxomil / 2.5-5mg of amlodipine or 8-16mg of azelnidipine
olmesartan medoxomil / low dose thiazide type drugDrug
AT1 subtype angiotensin II receptor antagonist / low dose diuretic : 5-40mg of olmesartan medoxomil / low dose thiazide type drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Composite of following events: Sudden death, Cerebrovascular events, Coronary events, Renal dysfunctionTime frame: 3 to 4.5 years (duration of planned treatment phase)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
COLM-Study Data Center
Kamiyacho Mount Bld.14F, 4-3-20 Toranomon Minato-ku, Tokyo, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.